clarithromycin has been researched along with Cancer of Eye in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donadoni, G; Ferreri, AJ; Govi, S; Kiesewetter, B; Raderer, M; Sassone, M; Scarfò, L | 1 |
| Crocchiolo, R; Dognini, GP; Ferreri, AJ; Govi, S; Licata, G; Ponzoni, M; Resti, AG | 1 |
| Doglioni, C; Dolcetti, R; Ferreri, AJ; Ponzoni, M | 1 |
2 trial(s) available for clarithromycin and Cancer of Eye
| Article | Year |
|---|---|
High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Breast Neoplasms; Clarithromycin; Colorectal Neoplasms; Disease-Free Survival; Eye Neoplasms; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Mouth Neoplasms; Neoplasms, Multiple Primary; Salvage Therapy; Skin Neoplasms; Stomach Neoplasms | 2015 |
Six-month oral clarithromycin regimen is safe and active in extranodal marginal zone B-cell lymphomas: final results of a single-centre phase II trial.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Clarithromycin; Conjunctival Neoplasms; Eye Neoplasms; Feasibility Studies; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Treatment Outcome | 2010 |
1 other study(ies) available for clarithromycin and Cancer of Eye
| Article | Year |
|---|---|
Unconventional therapies in ocular adnexal lymphomas.
Topics: Anti-Bacterial Agents; Chlamydophila psittaci; Clarithromycin; Eye Neoplasms; Humans; Lymphoma, B-Cell; Psittacosis | 2010 |